• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Brevetoxin 1

Brevetoxin 1

Product ID B6916
Cas No. 98112-41-5
Purity ≥95%
Product Unit SizeCostQuantityStock
100 µg $509.50 In stock
1 mg $3,820.20 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Brevetoxins are lipid-soluble polyether neurotoxins initially produced by the dinoflagellate Karenia brevis. Brevetoxins act as agonists, binding the neurotoxin site 5 on SCN4A/Nav1.4 and SCN5A/Nav1.5 voltage-gated Na+ channels in skeletal muscle and cardiac tissue, producing a channel opening effect; this activity results in bronchoconstriction and airway inflammation in vivo. Stimulation of the voltage-gated Na+ channels also induces NMDA receptor-mediated release of L-glutamate and L-aspartate in neurons. Brevetoxin 1 is a type A brevetoxin that induces bradycardia in exposed fish embryos.

Product Info

Cas No.

98112-41-5

Purity

≥95%

Formula

C49H70O13

Formula Wt.

867.20

Synonym

PbTx-1

Appearance

White Film

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

Info Sheet

B6916 Info Sheet PDF

References

Zaias J, Fleming LE, Baden DG, et al. Repeated exposure to aerosolized brevetoxin-3 induces prolonged airway hyperresponsiveness and lung inflammation in sheep. Inhal Toxicol. 2011 Mar;23(4):205-11. PMID: 21456953.

Liberona JL, Cárdenas JC, Reyes R, et al. Sodium-dependent action potentials induced by brevetoxin-3 trigger both IP3 increase and intracellular Ca2+ release in rat skeletal myotubes. Cell Calcium. 2008 Sep;44(3):289-97. PMID: 18276006.

Cao Z, George J, Baden DG, et al. Brevetoxin-induced phosphorylation of Pyk2 and Src in murine neocortical neurons involves distinct signaling pathways. Brain Res. 2007 Dec 12;1184:17-27. PMID: 17963734.

Colman JR, Ramsdell JS. The type B brevetoxin (PbTx-3) adversely affects development, cardiovascular function, and survival in Medaka (Oryzias latipes) embryos. Environ Health Perspect. 2003 Dec;111(16):1920-5. PMID: 14644667.

Bottein Dechraoui MY, Ramsdell JS. Type B brevetoxins show tissue selectivity for voltage-gated sodium channels: comparison of brain, skeletal muscle and cardiac sodium channels. Toxicon. 2003 Jun;41(7):919-27. PMID: 12782093.

Berman FW, Murray TF. Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons. J Pharmacol Exp Ther. 1999 Jul;290(1):439-44. PMID: 10381810.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C4457

    Clomipramine Hydrochloride

    FIASMA, mAChR, 5-HT2/3/6/7, α1/2-adrenergic antag...
    ≥98%
  • B5074

    BMS-599626

    EGFR, VEGFR inhibitor.
    ≥98%
  • S1069

    Scriptaid

    HDAC inhibitor.
    ≥98%
  • L1786

    Levofloxacin Hydrochloride Monohydrate

    Fluoroquinolone, S-(-) isomer of ofloxacin; topois...
    ≥90%
  • C6018

    C-Peptide, dog

    Endogenous peptide, connects A and B chains of ins...
    ≥95%
  • Z160021

    Zearalanone

    Mycotoxin.
    ≥97%
  • P0346

    Palosuran Hydrochloride

    Urotensin II receptor antagonist.
  • D0353

    Danofloxacin Mesylate

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • D3357

    Diosmin

    Flavone found in Teucrium.
    ≥95%
  • T7044

    Triamcinolone Acetonide Acetate

    Steroid; glucocorticoid agonist.
    ≥97%
  • S5753

    Somatostatin-28 (1-14)

    Endogenous neuropeptide hormone; somatostatin agon...
    ≥95%
  • T6932

    Triflumizole

    Imidazole; PPARγ agonist, RORγ inverse agonist, ...
    ≥95%
  • P4560

    Proteolipid Protein (139-151)

    Immunodominant peptide fragment of PLP, used to in...
    ≥95%
  • B0025

    Bafilomycin A1

    Macrolide antibiotic; vacuolar H+ ATPase inhibitor...
    ≥90%
  • C3214

    CID-797718

    Potential PKD binding agent.
    ≥99%
  • R1985

    Reveromycin A

    Isoleucyl-tRNA synthase inhibitor, osteoclast prot...
    ≥98%
  • I5208

    INCB-28060

    c-MET inhibitor.
    ≥98%
  • N1994

    Neurotensin, frog

    Endogenous neuropeptide involved in hormone releas...
    ≥95%
  • A1217

    Adefovir

    Acyclic nucleotide (adenosine) analog; viral DNA p...
    ≥98%
  • S8010

    [Nle11]-Substance P

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only